Kymera Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $17M | 675k | 25.46 |
| 2023-09-30 | $2.8M | 205k | 13.90 |
| 2023-06-30 | $7.9M | 342k | 22.99 |
| 2023-03-31 | $8.8M | 297k | 29.63 |
| 2022-12-31 | $8.4M | 338k | 24.96 |
| 2022-06-30 | $5.5M | 277k | 19.69 |
| 2022-03-31 | $10M | 244k | 42.32 |
| 2021-12-31 | $17M | 268k | 63.49 |
| 2021-09-30 | $11M | 180k | 58.74 |
| 2021-03-31 | $563k | 15k | 38.84 |
| 2020-12-31 | $1.7M | 28k | 62.01 |
| 2020-09-30 | $4.8M | 148k | 32.31 |